<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Follow-up Frequency and Compliance in Women with Probably Benign Findings on Breast Magnetic Resonance Imaging" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/follow-up-frequency-and-compliance-in-women-with-probably-benign-findings-on-breast-magnetic-resonan/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/follow-up-frequency-and-compliance-in-women-with-probably-benign-findings-on-breast-magnetic-resonan/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2012-03-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Follow-up Frequency and Compliance in Women with Probably Benign Findings on Breast Magnetic Resonance Imaging" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T02:43:55+00:00","datePublished":"2012-03-31T17:00:00+00:00","description":"Rationale and Objectives","headline":"Follow-up Frequency and Compliance in Women with Probably Benign Findings on Breast Magnetic Resonance Imaging","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/follow-up-frequency-and-compliance-in-women-with-probably-benign-findings-on-breast-magnetic-resonan/"},"url":"https://clinicaltree.github.io/posts/follow-up-frequency-and-compliance-in-women-with-probably-benign-findings-on-breast-magnetic-resonan/"}</script><title>Follow-up Frequency and Compliance in Women with Probably Benign Findings on Breast Magnetic Resonance Imaging | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Follow-up Frequency and Compliance in Women with Probably Benign Findings on Breast Magnetic Resonance Imaging</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Follow-up Frequency and Compliance in Women with Probably Benign Findings on Breast Magnetic Resonance Imaging</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1333213200" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Mar 31, 2012 </em> </span> <span> Updated <em class="" data-ts="1681094635" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Ariela L. Marshall MD</a> </em>, <em> <a href="">Susan M. Domchek MD</a> </em>, <em> <a href="">Susan P. Weinstein MD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="1712 words"> <em>9 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Six-month short-interval follow-up is recommended for probably benign findings on breast magnetic resonance imaging (MRI). We wanted to examine patient adherence to follow-up recommendation for Breast Imaging-Reporting and Data System (BI-RADS) category 3 lesions at a tertiary care medical center.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>We performed a retrospective review of frequency and adherence rates to follow-up recommendation for women with an initial BI-RADS 3 breast MRI between 2005 and 2007.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>A total of 132 women with BI-RADS 3 breast MRI recommendations were included. Ninety-six of 132 (72.7%) women adhered to the first follow-up recommendation or elected to have tissue diagnosis; 78/132 (59.1%) had follow-up MRI and 18/132 (13.6%) had tissue diagnosis. Thirty-six of 132 (27.3%) women did not return for follow-up. Nine of nine (100%) of BRCA carriers returned for follow-up or had tissue diagnosis, compared to 87/123 (70.7%) of non-BRCA carriers. A total of 35/41 (85.4%) of patients with a prior history of breast cancer returned for follow-up or had tissue diagnosis, compared to 61/91 (67%) of patients without a history of breast cancer. Only 5/15 (33%) of patients undergoing MRI for symptom alone adhered to follow-up recommendations.</p><h2 id="conclusion"><span class="mr-2">Conclusion</span><a href="#conclusion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Adherence to BI-RADS category 3 follow-up recommendation is often low. Women with a history of breast cancer or who were BRCA carriers were significantly more likely to adhere to follow-up recommendation than women without a history of breast cancer or women undergoing MRI for symptoms alone. Strategies to improve adherence should be developed.</p><p>Breast cancer is the most commonly diagnosed female malignancy in the United States with the exception of non-melanoma skin cancer, with an estimated incidence of 209,060 new cases in 2010 . Mammography is currently the accepted standard for the detection of early breast cancers . However, sensitivity of mammography varies significantly with breast density . The sensitivity of breast magnetic resonance imaging (MRI) approaches 100% for invasive breast cancer. Breast MRI is highly sensitive even for mammographically occult invasive breast malignancies , and sensitivity of MRI is superior to mammography in women with dense breasts .</p><p>Because of its high sensitivity for invasive breast cancer, breast MRI is used as a screening tool in high-risk patients. Several studies of women at more than 20%–25% risk of breast cancer demonstrated that MRI has superior sensitivity compared to mammography, without a significant decrease in specificity . Breast MRI is currently recommended by the American Cancer Society as an adjunct to mammography in women at high risk for developing breast cancer, including women with BRCA mutations, women with a lifetime risk of 20%–25% or higher based on risk assessment models, or those with a history of chest irradiation.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="study-population"><span class="mr-2">Study Population</span><a href="#study-population" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="mri-technique-interpretation-and-reporting"><span class="mr-2">MRI Technique, Interpretation, and Reporting</span><a href="#mri-technique-interpretation-and-reporting" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="data-collection"><span class="mr-2">Data Collection</span><a href="#data-collection" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="statistical-analysis"><span class="mr-2">Statistical Analysis</span><a href="#statistical-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Patient Characteristics</p><p>Number Percent Total number of patients 132 Length of follow-up (months) Mean 34.8 Median 37 Range 4–65 Age Mean 51.9 Median 51 Range 25–81 Prior history of breast cancer Yes 41 31.06 No 91 68.94 Indication for magnetic resonance imaging Abnormal mammogram 28 21.21 BRCA, no history of cancer 7 5.3 BRCA, history of cancer 2 1.52 Clinical symptom 15 11.36 History of breast cancer 34 25.76 History of breast cancer plus other risk factor 5 3.79 Other high risk patient 29 21.97 Other/combined 12 9.09 History of BRCA mutation Yes 9 6.82 No 123 93.18</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="adherence-with-follow-up-breast-mri"><span class="mr-2">Adherence with Follow-up Breast MRI</span><a href="#adherence-with-follow-up-breast-mri" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="outcomes-of-follow-up-breast-mri"><span class="mr-2">Outcomes of Follow-up Breast MRI</span><a href="#outcomes-of-follow-up-breast-mri" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/FollowupFrequencyandComplianceinWomenwithProbablyBenignFindingsonBreastMagneticResonanceImaging/0_1s20S1076633211005964.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/FollowupFrequencyandComplianceinWomenwithProbablyBenignFindingsonBreastMagneticResonanceImaging/0_1s20S1076633211005964.jpg" alt="Figure 1, A 40-year-old woman who had a high risk screening magnetic resonance imaging examination. An 8-mm enhancing mass was seen in the left breast at 2:00 posteriorly on the subtraction image (a) and the source image (b) . A 6-month follow-up was recommended, and the patient subsequently had a prophylactic mastectomy with ductal carcinoma in situ found on pathology. (a) Postcontrast sagittal subtraction image shows an 8-mm enhancing mass in the posterior breast. (b) The source image again demonstrates the mass in the posterior breast." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Estimated New Cancer Cases and Deaths for 2010. SEER Table I-1. http://seer.cancer.gov/csr/1975_2007/results_single/sect_01_table.01.pdf . Accessed July 8, 2010.</p><li><p>2. Smith R.A., Saslow D., Sawyer K.A., et. al.: American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin 2003; 53: pp. 141-169.</p><li><p>3. US Preventive Services Task Force: Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009; 151: pp. 716-726.</p><li><p>4. Elmore J.F., Armstrong K., Lehman C.D., et. al.: Screening for breast cancer. JAMA 2005; 293: pp. 1245-1256.</p><li><p>5. Carney P.A., Miglioretti D.L., Yankaskas B.C., et. al.: Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 2003; 138: pp. 168-175.</p><li><p>6. Helbich T.H.: Contrast-enhanced magnetic resonance imaging of the breast. Eur J Radiol 2000; 34: pp. 208-219.</p><li><p>7. Heywang S.H., Wolf A., Pruss E., et. al.: MR imaging of the breast with Gd-DTPA: use and limitations. Radiology 1989; 171: pp. 95-103.</p><li><p>8. Berg W.A., Gutierrez L., NesAiver M.S., et. al.: Diagnostic accuracy of mammography, clinical examination, US, and MRI imaging in preoperative assessment of breast cancer. Radiology 2004; 233: pp. 830-849.</p><li><p>9. Sardanelli F., Giuseppetti G.M., Panizza P., et. al.: Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in fatty and dense breasts using the whole-breast pathologic examination as a gold standard. AJR Am J Roentgenol 2004; 183: pp. 1149-1157.</p><li><p>10. Warner E., Plewes D.B., Hill K.A., et. al.: Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004; 292: pp. 1317-1325.</p><li><p>11. MARIBS study group: Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 2005; 365: pp. 1769-1778.</p><li><p>12. Kriege M., Brekelmans C.T.M., Boetes C., et. al.: Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004; 351: pp. 427-437.</p><li><p>13. Kuhl C.K., Schrading S., Leutner C.C., et. al.: Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005; 23: 8469–4876</p><li><p>14. Lehman C.D., Isaacs C., Schnall M.D., et. al.: Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. Radiology 2007; 244: pp. 381-388.</p><li><p>15. Sickles E.A.: Periodic mammographic follow-up of probably benign lesions: results in 3,184 consecutive cases. Radiology 1991; 179: pp. 463-468.</p><li><p>16. Kerlikowske K., Smith-Bindman R., Abraham L.A., et. al.: Breast cancer yield for screening mammographic examinations with recommendation for short-interval follow-up. Radiology 2005; 234: pp. 684-692.</p><li><p>17. Eby P.R., DeMartini W.B., Peacock S., et. al.: Cancer yield of probably benign breast MR examinations. J Magn Reson Imaging 2007; 26: pp. 950-955.</p><li><p>18. Weinstein S.P., Hanna L.G., Gatsonis C., et. al.: Frequency of malignancy seen in probably benign lesions at contrast-enhanced breast MR imaging: findings from ACRIN 6667. Radiology 2010; 255: pp. 731-737.</p><li><p>19. Gokalp G., Topal U.: MR imaging in probably benign lesions (BI-RADS category 3) of the breast. Eur J Radiol 2006; 57: pp. 436-444.</p><li><p>20. Liberman L., Morris E.A., Benton C.L., et. al.: Probably benign lesions at breast magnetic resonance imaging: preliminary experience in high-risk women. Cancer 2003; 98: pp. 377-388.</p><li><p>21. Balleyguier C., Ayadi S., Van Nguyen K., et. al.: BIRADS classification in mammography. Eur J Radiol 2007; 61: pp. 195-201.</p><li><p>22. Tardivon A.A., Athanasiou A., Thibault F., et. al.: Breast imaging and reporting data system (BIRADS): magnetic resonance imaging. Eur J Radiol 2007; 61: pp. 212-215.</p><li><p>23. Helvie M.A., Pennes D.R., Rebner M., et. al.: Mammographic follow-up of low-suspicion lesions: compliance rate and diagnostic yield. Radiology 1991; 178: pp. 155-158.</p><li><p>24. Vizcaino I., Gadea L., Andreo L., et. al.: Short-term follow-up results in 795 nonpalpable probably benign lesions detected at screening mammography. Radiology 2001; 219: pp. 475-483.</p><li><p>25. Masroor I.: Effectiveness of assigning BI-RADS category-3 to breast lesion with respect to follow-up. J Coll Physicians Surg Pak 2008; 18: pp. 209-212.</p><li><p>26. Duijm L.E., Zaat J.O., Guit G.L.: Nonpalpable, probably benign breast lesions in general practice: the role of follow-up mammography. Br J Gen Pract 1998; 48: pp. 1421-1423.</p><li><p>27. Taplin S.H., Ichikawa L.E., Kerlikowske K., et. al.: Concurrence of breast imaging reporting and data system assessments and management recommendations in screening mammography. Radiology 2002; 222: pp. 529-535.</p><li><p>28. De Neef P., Gandara J.: Experience with indeterminate mammograms. West J Med 1991; 154: pp. 36-39.</p><li><p>29. Baum J.K., Hanna L.G., Acharyya S., et. al.: Use of BI-RADS 3-probably benign category in the American College of Radiology Imaging Network Digital Mammographic Imaging Screening Trial. Radiology 2011; 260: pp. 61-67.</p><li><p>30. Yabroff K.R., Breen N., Vernon S.W., et. al.: What factors are associated with diagnostic follow-up after abnormal mammograms? Findings from a U.S. National Survey. Cancer Epidemiol Biomarkers Prev 2004; 13: pp. 723-732.</p><li><p>31. Butler P.F.: MQSA (Mammography Quality Standards Act) update—focusing on quality assurance. Radiol Manage 1998; 20: pp. 40-50.</p><li><p>32. Geller B.M., Ichikawa L.E., Buist D.S., et. al.: Improving the concordance of mammography assessment and management recommendations. Radiology 2006; 241: pp. 67-75.</p><li><p>33. Sickles E.A.: Probably benign breast lesions: when should follow-up be recommended and what is the optimal follow-up protocol?. Radiology 1999; 213: pp. 11-14.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-19/'>Volume 19</a>, <a href='/categories/issue-4/'>Issue 4</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Follow-up%20Frequency%20and%20Compliance%20in%20Women%20with%20Probably%20Benign%20Findings%20on%20Breast%20Magnetic%20Resonance%20Imaging%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Ffollow-up-frequency-and-compliance-in-women-with-probably-benign-findings-on-breast-magnetic-resonan%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Follow-up%20Frequency%20and%20Compliance%20in%20Women%20with%20Probably%20Benign%20Findings%20on%20Breast%20Magnetic%20Resonance%20Imaging%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Ffollow-up-frequency-and-compliance-in-women-with-probably-benign-findings-on-breast-magnetic-resonan%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Ffollow-up-frequency-and-compliance-in-women-with-probably-benign-findings-on-breast-magnetic-resonan%2F&text=Follow-up%20Frequency%20and%20Compliance%20in%20Women%20with%20Probably%20Benign%20Findings%20on%20Breast%20Magnetic%20Resonance%20Imaging%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/a-new-approach-to-assess-intracranial-white-matter-abnormalities-in-glaucoma-patients/"><div class="card-body"> <em class="small" data-ts="1333213200" data-df="ll" > Mar 31, 2012 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>A New Approach to Assess Intracranial White Matter Abnormalities in Glaucoma Patients</h3><div class="text-muted small"><p> Rationale and Objectives The aims of this study was to evaluate, using 3-T diffusion tensor imaging, changes of fractional anisotropy (FA) in the orbital and intracranial part of the optic nerve (...</p></div></div></a></div><div class="card"> <a href="/posts/baseline-suvmax-at-pet-ct-in-stage-iiia-non-small-cell-lung-cancer-patients-undergoing-surgery-after/"><div class="card-body"> <em class="small" data-ts="1333213200" data-df="ll" > Mar 31, 2012 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Baseline SUVmax at PET-CT in Stage IIIA Non-small-cell Lung Cancer Patients Undergoing Surgery after Neoadjuvant Therapy</h3><div class="text-muted small"><p> Rationale and Objectives To evaluate the prognostic significance of maximum standardized uptake value (SUVmax) at 18 F-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography in...</p></div></div></a></div><div class="card"> <a href="/posts/correlations-between-suvmax-and-expression-of-glut1-and-growth-factors-inducing-lymphangiogenesis/"><div class="card-body"> <em class="small" data-ts="1333213200" data-df="ll" > Mar 31, 2012 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Correlations between SUVmax and Expression of GLUT1 and Growth Factors Inducing Lymphangiogenesis</h3><div class="text-muted small"><p> Rationale and Objectives The purpose of this study was to assess the correlations between the maximum standardized uptake value (SUVmax) of colorectal carcinoma and hepatocyte growth factor (HGF),...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/exposure-creep-in-computed-radiography/" class="btn btn-outline-primary" prompt="Older"><p>Exposure Creep in Computed Radiography</p></a> <a href="/posts/imaging-of-the-spine-expert-radiology-series/" class="btn btn-outline-primary" prompt="Newer"><p>Imaging of the Spine Expert Radiology Series</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
